We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
10 Year Est. Return
AUM
$224M
AUM Growth
+$26.5M
Cap. Flow
+$16.5M
Cap. Flow %
7.39%
Top 10 Hldgs %
27.71%
Holding
558
New
25
Increased
144
Reduced
58
Closed
2

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$256K
2
BUD icon
AB InBev
BUD
+$191K
3
GE icon
GE Aerospace
GE
+$138K
4
GILD icon
Gilead Sciences
GILD
+$108K
5
INTC icon
Intel
INTC
+$72.9K

Sector Composition

Rank Sector Weight
1 Healthcare 17.74%
2 Technology 16.33%
3 Financials 12.83%
4 Industrials 8.85%
5 Communication Services 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VC icon
551
Visteon
VC
$2.82B
$144 ﹤0.01%
1
BHF icon
552
Brighthouse Financial
BHF
$3.59B
$95 ﹤0.01%
2
TTCF
553
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$84 ﹤0.01%
153
FG icon
554
F&G Annuities & Life
FG
$3.8B
$50 ﹤0.01%
2
INO icon
555
Inovio Pharmaceuticals
INO
$57.1M
$3 ﹤0.01%
1
AQB icon
556
AquaBounty Technologies
AQB
$4.59M
0
SHEL icon
557
Shell
SHEL
$251B
-75
Closed -$4.32K
SJM icon
558
J.M. Smucker
SJM
$12.9B
-100
Closed -$15.7K

Similar funds

Brown, Lisle/Cummings's Q2 2023 Portfolio in Review

As of Q2 2023, Brown, Lisle/Cummings held 558 positions worth $224M, up 13% from $197M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Brown, Lisle/Cummings deployed $16.5M of net new capital in Q2 2023, opening 25 new positions and adding to 144 existing holdings. Its largest new stake was Charles Schwab: 12,150 shares worth $689K.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $256K trimmed.

  • Brown, Lisle/Cummings's largest Q2 2023 buy was Charles Schwab: 12,150 shares worth $689K.
  • Brown, Lisle/Cummings added most to Canadian National Railway in Q2 2023, an estimated $1.38M increase.
  • Brown, Lisle/Cummings's biggest Q2 2023 reduction was Bristol-Myers Squibb, cutting an estimated $256K.
  • Brown, Lisle/Cummings fully exited J.M. Smucker in Q2 2023, selling an estimated $15.7K.
  • Brown, Lisle/Cummings's ten largest holdings make up 28% of its $224M portfolio in Q2 2023.
  • Brown, Lisle/Cummings opened 25 new positions and closed 2 in Q2 2023.
  • Brown, Lisle/Cummings's portfolio value rose 13% quarter-over-quarter to $224M.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2023, filed 1 Jul 2024.